HI
HRMY icon

Horizon Investments’s Harmony Biosciences HRMY Stock Holding History

Horizon Investments’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1M Buy
27,574
+2,926
+12% +$92.3K 0.01% 731
2026
Q1 		$690K Sell
24,648
-7,427
-23% -$244K 0.01% 799
2025
Q4 		$1.2M Buy
32,075
+2,159
+7% +$71K 0.02% 587
2025
Q3 		$824K Buy
29,916
+14,550
+95% +$501K 0.01% 670
2025
Q2 		$486K Buy
+15,366
New +$494K 0.01% 788

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Horizon Investments's HRMY Position: Q2 2026 in Review

Horizon Investments increased its Harmony Biosciences (HRMY) stake by 12% in Q2 2026, buying an estimated $92.3K and bringing the position to 27,574 shares worth $1M. The position accounts for 0.01% of the portfolio, ranked #731.

Horizon Investments first reported a position in HRMY in Q2 2025 and has held it in 5 quarters since. The position peaked at $1.2M in Q4 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Horizon Investments held 27,574 shares of Harmony Biosciences worth $1M as of Q2 2026.
  • Horizon Investments bought 2,926 Harmony Biosciences shares in Q2 2026, an estimated $92.3K.
  • Harmony Biosciences made up 0.01% of Horizon Investments's portfolio in Q2 2026, its #731 holding.
  • Horizon Investments first reported a position in Harmony Biosciences in Q2 2025 and has held it in 5 quarters since.
  • Horizon Investments's Harmony Biosciences position peaked at $1.2M in Q4 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Horizon Investments's 13F filing for Q2 2026, filed 13 Aug 2026.